Biomx End Period Cash Flow from 2010 to 2024

PHGE Stock  USD 0.54  0.05  10.20%   
Biomx's End Period Cash Flow is increasing over the years with slightly volatile fluctuation. Overall, End Period Cash Flow is expected to go to about 27.2 M this year. During the period from 2010 to 2024 Biomx End Period Cash Flow annual values regression line had geometric mean of  11,931,098 and mean square error of 180.1 T. View All Fundamentals
 
End Period Cash Flow  
First Reported
2018-06-30
Previous Quarter
32.7 M
Current Value
24.7 M
Quarterly Volatility
22.7 M
 
Covid
Check Biomx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biomx's main balance sheet or income statement drivers, such as Interest Expense of 2.5 M, Selling General Administrative of 7.4 M or Research Development of 14.7 M, as well as many indicators such as Dividend Yield of 0.0, Ptb Ratio of 5.03 or Book Value Per Share of 0.57. Biomx financial statements analysis is a perfect complement when working with Biomx Valuation or Volatility modules.
  
Check out the analysis of Biomx Correlation against competitors.

Latest Biomx's End Period Cash Flow Growth Pattern

Below is the plot of the End Period Cash Flow of Biomx Inc over the last few years. It is Biomx's End Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Biomx's overall financial position and show how it may be relating to other accounts over time.
End Period Cash Flow10 Years Trend
Slightly volatile
   End Period Cash Flow   
       Timeline  

Biomx End Period Cash Flow Regression Statistics

Arithmetic Mean16,599,240
Geometric Mean11,931,098
Coefficient Of Variation99.38
Mean Deviation12,453,019
Median6,993,000
Standard Deviation16,496,031
Sample Variance272.1T
Range56.1M
R-Value0.62
Mean Square Error180.1T
R-Squared0.39
Significance0.01
Slope2,289,958
Total Sum of Squares3809.7T

Biomx End Period Cash Flow History

202427.2 M
202315.9 M
202232.3 M
202163.1 M
202037.2 M
20188.7 M

About Biomx Financial Statements

Biomx stakeholders use historical fundamental indicators, such as Biomx's End Period Cash Flow, to determine how well the company is positioned to perform in the future. Although Biomx investors may analyze each financial statement separately, they are all interrelated. For example, changes in Biomx's assets and liabilities are reflected in the revenues and expenses on Biomx's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Biomx Inc. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
End Period Cash Flow15.9 M27.2 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Biomx Inc is a strong investment it is important to analyze Biomx's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Biomx's future performance. For an informed investment choice regarding Biomx Stock, refer to the following important reports:
Check out the analysis of Biomx Correlation against competitors.
You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomx. If investors know Biomx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.26)
Return On Assets
(0.33)
Return On Equity
(1.21)
The market value of Biomx Inc is measured differently than its book value, which is the value of Biomx that is recorded on the company's balance sheet. Investors also form their own opinion of Biomx's value that differs from its market value or its book value, called intrinsic value, which is Biomx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomx's market value can be influenced by many factors that don't directly affect Biomx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biomx's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.